JVM Co

JVM Co P/B

The P/B (Price-to-Book Ratio) of JVM Co (054950.KQ) as of Nov 3, 2026 is 1.29. In the previous year, P/B (Price-to-Book Ratio) was 1.49 — a change of -13.51% (lower).

P/B

1.29

YoY

-13.51%

Last updated:

P/B (Price-to-Book Ratio) of JVM Co is 2025 1.29 . P/B (Price-to-Book Ratio) of JVM Co was 2024 1.49 . It decreases by -13.51% lower compared to the previous year.

The JVM Co P/B history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

P/B
Date
P/B
Jan 1, 2018
2.45 KRW
Jan 1, 2019
2.44 KRW
Jan 1, 2020
2.19 KRW
Jan 1, 2021
2.10 KRW
Jan 1, 2022
1.90 KRW
Jan 1, 2023
1.68 KRW
Jan 1, 2024
1.49 KRW
Jan 1, 2025
1.29 KRW
The JVM Co P/B history
YEARP/BYoY
1.29-13.51%
1.49-11.29%
1.68-11.91%
1.90-9.25%
2.10-4.28%
2.19-10.01%
2.44-0.36%
2.45-1.64%
2.49-7.41%
2.69-6.48%
2.87-5.78%
3.05—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

JVM Co Stock analysis

What does JVM Co do? JVM Co., Ltd. manufactures pharmacy automation systems under the brand JVM, targeting domestic and overseas markets. The company's primary products include automatic tablet dispensing and packaging systems (ATDPSs), automatic tablet classification and packing machines available in slide, box, and drum types, total safety solutions, automatic medication vision inspection systems (VIZENs), automatic package cutting and winding systems (WIZERs), and automatic medication sorting and control systems (AccuPharm). These products are sold to customers in the pharmaceutical and healthcare sectors seeking efficient automation solutions for medication handling and safety. The firm generates revenue through the sale of its branded automation systems, with a focus on domestic distribution and international markets. JVM's product portfolio addresses key operational needs in pharmacy settings, including dispensing, classification, inspection, and sorting of medications, ensuring compliance with safety standards while improving workflow efficiency. The company's offerings are designed to meet the demands of healthcare providers and pharmaceutical manufacturers requiring advanced automation technologies. JVM's business model centers on providing comprehensive automation solutions for pharmacy operations, leveraging its established brand JVM to differentiate its products in the market. By offering a wide range of specialized systems, the company caters to both domestic and international clients seeking reliable, high-quality automation equipment for medication management and safety protocols. JVM Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about JVM Co stock

P/B (Price-to-Book Ratio) of JVM Co is 1.29 in 2025.

P/B (Price-to-Book Ratio) of JVM Co changed from 1.49 to 1.29, representing a -13.51% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of P/B (Price-to-Book Ratio) JVM Co since 2006 – with annual values, charts, and detailed analysis.

The Price-to-Book ratio compares a company's market price to its book value. A low P/B may indicate an undervalued stock, while a high P/B could suggest overvaluation or strong growth expectations.

P/B = Stock Price / Book Value per Share

To evaluate P/B (Price-to-Book Ratio)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for P/B (Price-to-Book Ratio).

A 'good' varies by industry and company stage. On Eulerpool, you can compare P/B (Price-to-Book Ratio)'s JVM Co with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Valuation — JVM Co

P/EP/SEV/EBITP/BP/CFP/FCFPEGEV/RevenueEV/EBITDAEV/FCFEarnings YieldFCF YieldMarket capitalizationEnterprise ValueForward P/EP/TBVShareholder YieldBuyback YieldDiv.-Adj. PEGEV/OCF

All Key Metrics — JVM Co